Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 40 or older who have been diagnosed with confirmed Parkinson's disease by a neurologist who specialises in movement disorders, using standard diagnostic criteria
- People whose Parkinson's disease was diagnosed based on symptoms that started on one side of the body and included at least 3 of the main signs of Parkinson's (muscle stiffness, slowness of movement, tremor, or balance problems)
- People whose Parkinson's symptoms clearly improve when taking Parkinson's medications (such as reduced stiffness, slowness, or tremor)
- People at Hoehn and Yahr (H&Y) disease stages 2, 2.5, or 3 — a rating scale used to measure how advanced Parkinson's disease is (confirm with trial site)
- People who score above 17 on the Montreal Cognitive Assessment (MoCA), a standard memory and thinking test
- People who are able to walk at least 10 feet, with or without a walking aid
- People whose vision, with glasses or other correction, is better than 20/70 in their better eye
- People who are fluent in English
- People who are willing to be randomly assigned to a treatment group
Who may not be able to join:
- People with untreated major depression or serious psychiatric illness
- People with a history of stroke or traumatic brain injury
- People with significant hearing loss at certain sound frequencies (confirm with trial site)
- People who drink alcohol heavily or regularly use antipsychotic medications
- People who plan to leave the local area for more than one month during the study period
- People taking medium to high doses of beta-blocker medications if their resting heart rate is below 60 beats per minute, because the study measures exercise intensity using heart rate
- People with serious heart conditions, including advanced heart failure, significant narrowing of the aortic heart valve, a history of cardiac arrest, use of an implanted heart defibrillator, or chest pain that is not well controlled
- People with other serious health conditions that would prevent them from taking part in an exercise-based programme, such as kidney failure requiring dialysis or drinking more than 14 alcoholic drinks per week
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Madeleine E. Hackney, PhD, Atlanta VA Medical and Rehab Center, Decatur, GA
Phone: (404) 321-6111
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Gait cadence; Physical activity scale for the elderly (PASE); vascular function: Pulse wave velocity and Aortic index
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.